A look at the types of visits and treatments prescribed via teledermatology during the pandemic reinforces the staying power of virtual acne care; statistics offer key details.
During the height of the pandemic, telemedicine became a required medium to provide care. A 2021 study at Weill Cornell Medicine in New York1 and a 2022 letter from the University of Naples Federico II in Italy2 look at the types of patients with acne and treatments prescribed via telemedicine and in-person during the pandemic and how that compares to telemedicine use after restrictions eased. The retrospective analyses looked at primary visits from March to May of 2020 with follow up visits from June to December 2020 in New York and all visits from March 2020 to December 2021 in Naples. Findings were as follows:
1.Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38. doi:10.1111/jocd.14606
2.Luca P, Fabbrocini G, Villani A. Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38." [published online ahead of print, 2022 Apr 23]. J Cosmet Dermatol. 2022;10.1111/jocd.15018. doi:10.1111/jocd.15018